Unicycive Therapeutics, Inc.UNCYNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-32.12M
↓ 165% below average
Average (6y)
$-12.12M
Historical baseline
Range
High:$-952000.00
Low:$-32.12M
CAGR
+79.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-32.12M | -54.6% |
| 2023 | $-20.77M | -15.1% |
| 2022 | $-18.05M | -101.1% |
| 2021 | $-8.98M | -344.4% |
| 2020 | $-2.02M | -2.9% |
| 2019 | $-1.96M | -106.2% |
| 2018 | $-952000.00 | - |